TREATMENT OF DEPRESSION.
D000661:Amphetamine; D000662:Amphetamines; D000928:Antidepressive Agents; D002395:Catecholamines; D003863:Depression; D003866:Depressive Disorder; D004358:Drug Therapy; D004565:Electroconvulsive Therapy; D007099:Imipramine; D007490:Iproniazid; D007520:Isocarboxazid; D008660:Metabolism; D008996:Monoamine Oxidase Inhibitors; D010600:Pharmacology; D010624:Phenelzine; D012701:Serotonin; D014116:Toxicology; D014191:Tranylcypromine
D000662:Amphetamines; D000928:Antidepressive Agents; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D007520:Isocarboxazid; D014191:Tranylcypromine; D000661:Amphetamine; D007490:Iproniazid; D010624:Phenelzine; D007099:Imipramine
AMPHETAMINE; ANTIDEPRESSIVE AGENTS; CATECHOLAMINES; DEPRESSION; DRUG THERAPY; IMIPRAMINE; IPRONIAZID; ISOCARBOXAZID; METABOLISM; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; PHENELZINE; SEROTONIN; SHOCK THERAPY, ELECTRIC; TOXICOLOGIC REPORT; TRANYLCYPROMINE